Trump meets Novartis CEO, says drugmaker building 11 US plants

ROME, Georgia, Feb 19 (Reuters) – U.S. President Donald Trump said he met Vas Narasimhan, the chief executive officer of Swiss drugmaker Novartis, at the White House on Wednesday.
Trump, addressing workers at a steel plant in Rome, Georgia on Thursday, said Narasimhan told him during the meeting that his company was building 11 U.S. plants as ⁠a result of the president’s tariff policies.
“We appreciate the opportunity to update ⁠the U.S. government on our progress, including recent groundbreakings for manufacturing and research facilities in North Carolina and California and plans to expand our radioligand therapy manufacturing network with a new site in Florida,” a spokesperson for Novartis told Reuters in an emailed statement.
“We appreciate the opportunity to update ⁠the U.S. government on our progress, including recent groundbreakings for manufacturing and research facilities in North Carolina and California and plans to expand our radioligand therapy manufacturing network with a new site in Florida,” a spokesperson for Novartis told Reuters in an emailed statement.
The statement did not add any details on the number of facilities planned in the U.S.
Last year, the Swiss drugmaker said it planned to spend $23 billion to build and expand 10 facilities in the U.S. after the Trump administration threatened to impose drug import duties.